Details

Autor(en) / Beteiligte

• Nordmann, Sandra
• Lions, Caroline
• Vilotitch, Antoine
• Michel, Laurent
• Mora, Marion
• Spire, Bruno
• Maradan, Gwenaelle
• Morel, Alain
• Roux, Perrine
• Carrieri, M. Patrizia

Titel

A prospective, longitudinal study of sleep disturbance and comorbidity in opiate dependence (the ANRS Methaville study)

Ist Teil von

• Psychopharmacology, 2016-04, Vol.233 (7), p.1203-1213

Ort / Verlag

Berlin/Heidelberg: Springer Berlin Heidelberg

Erscheinungsjahr

2016

Quelle

Psychology & Behavioral Sciences Collection

Beschreibungen/Notizen

• Rationale/objectives Sleep disturbance is frequent in opioid-dependent patients. To date, no data are available about the impact of methadone maintenance treatment on sleep disturbance. Using 1-year follow-up data from the Methaville trial, we investigated the impact of methadone initiation and other correlates on sleep disturbance in opioid-dependent patients. Methods Sleep disturbance severity was evaluated using two items from different scales (Center for Epidemiological Studies Depression Scale for depression and Opiate Treatment Index). We assessed the effect of methadone and other correlates on sleep disturbance severity during follow-up (months 0, 6, and 12) using a mixed multinomial logistic regression model. Results We included 173 patients who had 1-year follow-up data on sleep disturbance, corresponding to 445 visits. At enrolment, 60.5 % reported medium to severe sleep disturbance. This proportion remained stable during methadone treatment: 54.0 % at month 6 and 55.4 % at month 12. The final multivariate model indicated that younger patients (odds ratio (OR) [95 % CI] 0.95 [0.90–1.00]), patients with pain (OR [95 % CI] 2.45 [1.13–5.32]), patients with high or very high nicotine dependence (OR [95 % CI] 5.89 [2.41–14.39]), and patients at suicidal risk (2.50 [1.13–5.52]) had a higher risk of severe sleep disturbance. Because of collinearity between suicidal risk and attention deficit hyperactivity disorder (ADHD) symptoms, ADHD was not associated with sleep disturbance in the final model. Receiving methadone treatment had no significant effect on sleep disturbance. Conclusions Sleep disturbance is frequent among opioid-dependent patients. It can be regarded as an important signal of more complex psychiatric comorbidities such as suicidal risk and ADHD. However, sleep disturbance should not be considered an obstacle to methadone maintenance treatment (MMT) initiation or continuation.